How much does IMKELDI cost?

Pricing for IMKELDI varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does IMKELDI need prior authorization?

IMKELDI appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for IMKELDI?

Yes — the manufacturer copay card link is available on this page. A patient assistance program is also available for qualifying patients. Eligibility typically depends on insurance type and income. Click the CTA buttons above to apply directly through the manufacturer's portal.

What is IMKELDI used to treat?

IMKELDI (generic: imatinib oral) is indicated for Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Leukemia and 2 other conditions. Click any condition name on this page for more detail.

Does IMKELDI have a generic version?

The generic name for IMKELDI is imatinib oral. Whether a generic is currently available depends on patent status — check the FDA Orange Book or ask your pharmacist. Generics are often substantially cheaper than brand-name drugs.

IMKELDI

Generic: imatinib oral

Verified·Oct 26, 2026

Manufacturer: Sumitomo Pharma
NDC: 81927-201
RxCUI: 2699831
Route: ORAL
ICD-10 indication: C92.10

Affordability Check

How much will you actually pay for IMKELDI?

In 30 seconds, see every legitimate way to afford IMKELDI — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About IMKELDI

What is this medication? Myfembree is a prescription medication consisting of a combination of three active ingredients: relugolix, estradiol, and norethindrone acetate. This treatment is primarily indicated for premenopausal women to manage symptoms associated with two specific conditions. It is used to reduce heavy menstrual bleeding associated with uterine fibroids and to treat moderate to severe pain caused by endometriosis. By addressing these symptoms, the medication aims to improve the overall quality of life for individuals suffering from these reproductive health issues. The medication works by decreasing the amount of estrogen and progesterone produced by the ovaries through its gonadotropin-releasing hormone receptor antagonist component. To balance this effect, the included estradiol and norethindrone help to mitigate potential side effects like bone density loss and hot flashes that can occur when hormone levels are lowered. It is usually prescribed as a once-daily tablet to be taken at the same time each day. Patients should discuss their full medical history with a healthcare provider to ensure the medication is appropriate for their specific health needs and to understand the potential risks and benefits.

Copay & patient assistance

Patient Copay Amount: As little as $15 for a 30-day supply
Maximum Annual Benefit Limit: Not Publicly Available (The program covers up to $575 for a 30-day supply for up to 12 months)
Core Eligibility Restrictions: Limited to patients with commercial drug insurance; not valid for patients enrolled in government-funded programs (including Medicare, Medicaid, TRICARE, VA, or DoD); must be a resident of the U.S.; Massachusetts and California residents are ineligible if generic or therapeutic equivalents are available; cannot be combined with other discounts or cash offers.
RxBIN, PCN, and Group numbers: Not Publicly Available (Program is an automated, paperless electronic system applied at the pharmacy point of dispense; no cards or coupons are required)

Copay card →Patient Assistance Program →

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for imatinib oral.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup IMKELDI →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for imatinib oral →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How IMKELDI appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

79%

4,317 of 5,499 plans

Most common tier

Tier 5

On 79% of covering formularies

Prior authorization required

99%

of covering formularies

Tier	Formularies on this tier	Share
Tier 1 (preferred generic)	59	18%
Tier 2 (generic)	2	1%
Tier 4 (non-preferred brand)	7	2%
Tier 5 (specialty)	259	79%
Tier 6	1	0%

Step therapy: 0% of formularies

Quantity limits: 86% of formularies

Coverage breadth: 328 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

IMKELDI treats 3 rare conditions. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.